참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 7-Bromo-1-benzofuran | HCID 113628 | — |
| 반응물 | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| 시약 | Sodium t-butoxide | HCID 23676156 | — |
| 촉매 | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| 촉매 | 2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl | HCID 11155794 | — |
| 용매 | Toluene | HCID 1140 | — |
| 생성물 | Tert-butyl 4-(7-benzo[b]furanyl)piperazine-1-carboxylate | HCID 23300012 | 84.06% |
반응 단계
7-bromobenzofuran (2 g, 10.15 mmol), tert-Butyl 1-piperazinecarboxylate (1.891 g, 10.15 mmol), Tris(dibenzylideneacetone)dipalladium(0) (0.465 g, 0.51 mmol), 2-Dicyclohexylphosphino-2',4',6'-tri-iso-propyl-1,1'-biphenyl (0.484 g, 1.02 mmol) and sodium t-butoxide (1.856 mL, 21.32 mmol) were heated to 100 °C in toluene (10 mL) for 3h. The mixture was allowed to cool to ambient temperature. Ethylacetate was added and the mixture was filtered through Celite. The filtrate was concentrated and redissolved in ethylacetate. The organic mixture was washed with satd. aqueous Na2CO3 and brine. The organic phase was separated, dried over Na2CO3, filtered and the solvent removed by rotary evaporation. The crude product was redissolved in diethylether and loaded onto a silica gel column and eluted with 0-50% EtOAc in heptanes. The collected fractions were combined and the solvent removed by rotary evaporation to yield tert-butyl 4-(benzofuran-7-yl)piperazine-1-carboxylate (2.58 g, 84 %). MS (m+1) = 303. HPLC Peak RT = 5.97 minutes is product. Purity = 94%.
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-decd3260950345c1bc7b269e3329c8ac |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|